CN103896888B - 枸橼酸铋雷尼替丁的制备方法 - Google Patents
枸橼酸铋雷尼替丁的制备方法 Download PDFInfo
- Publication number
- CN103896888B CN103896888B CN201410122180.0A CN201410122180A CN103896888B CN 103896888 B CN103896888 B CN 103896888B CN 201410122180 A CN201410122180 A CN 201410122180A CN 103896888 B CN103896888 B CN 103896888B
- Authority
- CN
- China
- Prior art keywords
- bismuth citrate
- ranitidine
- dehydrated alcohol
- preparation
- citrate ranitidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- KKMOSYLWYLMHAL-UHFFFAOYSA-N 2-bromo-6-nitroaniline Chemical compound NC1=C(Br)C=CC=C1[N+]([O-])=O KKMOSYLWYLMHAL-UHFFFAOYSA-N 0.000 title claims abstract description 51
- 229960000620 ranitidine Drugs 0.000 title claims abstract description 41
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 39
- 229960000935 dehydrated alcohol Drugs 0.000 claims abstract description 39
- GGWBHVILAJZWKJ-KJEVSKRMSA-N ranitidine hydrochloride Chemical compound [H+].[Cl-].[O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 GGWBHVILAJZWKJ-KJEVSKRMSA-N 0.000 claims abstract description 21
- 238000003756 stirring Methods 0.000 claims abstract description 17
- 238000000967 suction filtration Methods 0.000 claims abstract description 11
- 239000000706 filtrate Substances 0.000 claims abstract description 9
- 159000000000 sodium salts Chemical class 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 7
- 238000009413 insulation Methods 0.000 claims abstract description 5
- 238000002425 crystallisation Methods 0.000 claims abstract description 4
- 230000008025 crystallization Effects 0.000 claims abstract description 4
- 238000001035 drying Methods 0.000 claims abstract description 3
- 239000012065 filter cake Substances 0.000 claims abstract description 3
- 238000001514 detection method Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- RMGVZKRVHHSUIM-UHFFFAOYSA-L dithionate(2-) Chemical compound [O-]S(=O)(=O)S([O-])(=O)=O RMGVZKRVHHSUIM-UHFFFAOYSA-L 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 claims description 5
- 229960001520 ranitidine hydrochloride Drugs 0.000 claims description 5
- 238000010186 staining Methods 0.000 claims description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 229960000907 methylthioninium chloride Drugs 0.000 claims description 4
- HSXUHWZMNJHFRV-QIKYXUGXSA-L orange G Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1\N=N\C1=CC=CC=C1 HSXUHWZMNJHFRV-QIKYXUGXSA-L 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 3
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 2
- 239000000920 calcium hydroxide Substances 0.000 claims description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 2
- 235000011116 calcium hydroxide Nutrition 0.000 claims description 2
- -1 carminum Chemical compound 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- 238000010792 warming Methods 0.000 claims description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 claims 2
- 239000012535 impurity Substances 0.000 abstract description 5
- 239000000047 product Substances 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- DXASQZJWWGZNSF-UHFFFAOYSA-N n,n-dimethylmethanamine;sulfur trioxide Chemical group CN(C)C.O=S(=O)=O DXASQZJWWGZNSF-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- PODWXQQNRWNDGD-UHFFFAOYSA-L sodium thiosulfate pentahydrate Chemical compound O.O.O.O.O.[Na+].[Na+].[O-]S([S-])(=O)=O PODWXQQNRWNDGD-UHFFFAOYSA-L 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- QEPCRAGGRXDAIP-UHFFFAOYSA-N CCC(C)[Na] Chemical compound CCC(C)[Na] QEPCRAGGRXDAIP-UHFFFAOYSA-N 0.000 description 1
- HXRDIZJXWOAWGI-UHFFFAOYSA-N [Na+].O[S-](=O)=O Chemical compound [Na+].O[S-](=O)=O HXRDIZJXWOAWGI-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
Abstract
Description
实施例1 | 实施例2 | 实施例3 | |
实例2自制无水乙醇 | 1000mL | 800mL | 1200mL |
枸橼酸铋雷尼替丁/g | 21.8 | 19.5g | 21.0 |
收率/% | 88 | 80 | 85 |
雷尼替丁含量/% | 41.0 | 41.3 | 40.9 |
铋含量/% | 29.3 | 30.1 | 28.7 |
最大单杂含量/% | 0.25 | 0.24 | 0.27 |
总杂含量/% | 0.97 | 0.88 | 1.15 |
实施例4 | 实施例5 | 实施例6 | |
实例3自制无水乙醇 | 1000mL | 800mL | 1200mL |
枸橼酸铋雷尼替丁/g | 21.3 | 19.0 | 20.4 |
收率/% | 86 | 78 | 83 |
雷尼替丁含量/% | 40.1 | 40.4 | 39.8 |
铋含量/% | 27.9 | 28.2 | 27.6 |
最大单杂含量/% | 0.41 | 0.34 | 0.45 |
总杂含量/% | 1.42 | 1.37 | 1.53 |
对比例1 | 对比例2 | 对比例3 | |
市售的工业级无水乙醇 | 1000mL | 800mL | 1200mL |
枸橼酸铋雷尼替丁/g | 21.0 | 18.7 | 20.0 |
收率/% | 85 | 77 | 82 |
雷尼替丁含量/% | 38.8 | 39.2 | 38.3 |
铋含量/% | 26.8 | 27.3 | 26.4 |
最大单杂含量/% | 1.14 | 1.05 | 1.21 |
总杂含量/% | 2.05 | 1.97 | 2.22 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410122180.0A CN103896888B (zh) | 2014-03-28 | 2014-03-28 | 枸橼酸铋雷尼替丁的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410122180.0A CN103896888B (zh) | 2014-03-28 | 2014-03-28 | 枸橼酸铋雷尼替丁的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103896888A CN103896888A (zh) | 2014-07-02 |
CN103896888B true CN103896888B (zh) | 2015-11-18 |
Family
ID=50988509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410122180.0A Active CN103896888B (zh) | 2014-03-28 | 2014-03-28 | 枸橼酸铋雷尼替丁的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103896888B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107382921A (zh) * | 2017-07-28 | 2017-11-24 | 常州兰陵制药有限公司 | 制备枸橼酸铋雷尼替丁的方法 |
CN107501216B (zh) * | 2017-08-03 | 2021-01-19 | 江苏汉斯通药业有限公司 | 高稳定性枸缘酸铋雷尼替丁的合成新方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1039419A (zh) * | 1988-07-18 | 1990-02-07 | 格拉克索公司 | 呋喃衍生物制备方法 |
CN1236779A (zh) * | 1999-04-28 | 1999-12-01 | 常州市第二制药厂 | 雷尼替丁枸橼酸铋盐的制备方法 |
CN1903850A (zh) * | 2006-08-01 | 2007-01-31 | 丽珠医药集团股份有限公司 | 一种制备枸橼酸铋雷尼替丁的方法 |
CN102408398A (zh) * | 2011-09-20 | 2012-04-11 | 江苏汉斯通药业有限公司 | 枸橼酸铋雷尼替丁的制备方法 |
-
2014
- 2014-03-28 CN CN201410122180.0A patent/CN103896888B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1039419A (zh) * | 1988-07-18 | 1990-02-07 | 格拉克索公司 | 呋喃衍生物制备方法 |
CN1236779A (zh) * | 1999-04-28 | 1999-12-01 | 常州市第二制药厂 | 雷尼替丁枸橼酸铋盐的制备方法 |
CN1903850A (zh) * | 2006-08-01 | 2007-01-31 | 丽珠医药集团股份有限公司 | 一种制备枸橼酸铋雷尼替丁的方法 |
CN102408398A (zh) * | 2011-09-20 | 2012-04-11 | 江苏汉斯通药业有限公司 | 枸橼酸铋雷尼替丁的制备方法 |
Non-Patent Citations (1)
Title |
---|
雷尼替丁枸橼酸铋的制备;王健祥;《中国医药工业杂志》;20051231;第36卷(第5期);259-260 * |
Also Published As
Publication number | Publication date |
---|---|
CN103896888A (zh) | 2014-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105330609B (zh) | 一种制备lcz696的方法 | |
CN103896888B (zh) | 枸橼酸铋雷尼替丁的制备方法 | |
CN105566215B (zh) | 一种瑞戈非尼的制备方法 | |
CN102250025B (zh) | 一种适合工业化生产奥替拉西钾的制备方法 | |
CN103601777A (zh) | 一种卡培他滨的制备方法 | |
CN104557576B (zh) | 一种高纯度普瑞巴林的制备方法 | |
CN103319462B (zh) | 氯吡嘧磺隆的制备方法 | |
CN102850381A (zh) | 头孢替安盐酸盐粗品的制备方法 | |
CN104829590A (zh) | 一种纯化曲格列汀的方法 | |
US9409940B2 (en) | Preparation process of erythromycin thiocyanate | |
CN108424389A (zh) | 一种伊伐布雷定杂质的制备方法 | |
CN104478974B (zh) | 一种20,23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的合成方法 | |
CN105272911B (zh) | 一种对甲苯磺酸索拉非尼的制备方法 | |
CN105017284B (zh) | 头孢唑肟丙匹酯的制备方法及其中间体和中间体的制备方法 | |
CN103724360B (zh) | 吡啶(或苯)并噻唑化合物及其中间体、制备方法和应用 | |
CN106866560B (zh) | 一种Lesinurad的合成方法 | |
CN106432327A (zh) | 一种索非布韦关键中间体的制备方法 | |
CN101857575A (zh) | 2-氨基-5-甲基吡嗪的工业化制备方法 | |
CN103467355A (zh) | 一种吲达帕胺的制备方法 | |
CN109265377B (zh) | 贝利司他的绿色合成方法 | |
CN108329322B (zh) | 一种维格列汀环脒杂质的制备方法 | |
CN111362957B (zh) | 一种埃克替尼关键中间体的制备方法 | |
CN106432328A (zh) | 一种索非布韦中间体的制备方法 | |
CN105294592B (zh) | 一种胺化合物的制备方法 | |
CN105250228B (zh) | 一种吉非替尼的片剂及其原料的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right |
Effective date of registration: 20160308 Granted publication date: 20151118 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20160908 Granted publication date: 20151118 |
|
RINS | Preservation of patent right or utility model and its discharge | ||
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20200722 Granted publication date: 20151118 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20230722 Granted publication date: 20151118 |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20230722 Granted publication date: 20151118 |